APO Research

APO RESEARCH · REPORT

Digital COPD Management

Selected research

Market Analysis & Forecast

Global Digital COPD Management Market Analysis and Forecast 2026-2032

Market perspective

The global Digital COPD Management market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Digital COPD Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Digital COPD Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Digital COPD Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Digital COPD Management is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Digital COPD Management include Teva Digital Health, AstraZeneca Digital Health, GSK Digital Health, Boehringer Ingelheim Digital Health, Huma Therapeutics, Biofourmis, Kaia Health, Ada Health and Current Health, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Digital COPD Management, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Digital COPD Management, also provides the revenue of main regions and countries. Of the upcoming market potential for Digital COPD Management, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Digital COPD Management revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Digital COPD Management market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Digital COPD Management revenue, projected growth trends, production technology, application and end-user industry.

Digital COPD Management Segment by Company

Teva Digital Health

AstraZeneca Digital Health

GSK Digital Health

Boehringer Ingelheim Digital Health

Huma Therapeutics

Biofourmis

Kaia Health

Ada Health

Current Health

Wellinks

Sensviv

ResMed Inc

Philips Respironics

Propeller Health

Digital COPD Management Segment by Type

Symptom Monitoring

Lung Function Management

Acute Exacerbation Prediction

Medication Adherence Management

Others

Digital COPD Management Segment by Application

Hospital Respiratory Department Management

Home Health Self-Management

Insurance-Based Health Management

Telemedicine

Digital COPD Management Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital COPD Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital COPD Management and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital COPD Management.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Digital COPD Management in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Digital COPD Management company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital COPD Management revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Digital COPD Management Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Symptom Monitoring Major Player Table 3. Lung Function Management Major Player Table 4. Acute Exacerbation Prediction Major Player Table 5. Medication Adherence Management Major Player Table 6. Others Major Player Table 7. Global Digital COPD Management Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Respiratory Department Management Major Player Table 9. Home Health Self-Management Major Player Table 10. Insurance-Based Health Management Major Player Table 11. Telemedicine Major Player Table 12. Digital COPD Management Industry Trends Table 13. Digital COPD Management Industry Drivers Table 14. Digital COPD Management Industry Opportunities and Challenges Table 15. Digital COPD Management Industry Restraints Table 16. Global Digital COPD Management Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 17. Global Digital COPD Management Market Size by Region (2021-2026) & (US$ Million) Table 18. Global Digital COPD Management Market Share by Region (2021-2026) Table 19. Global Digital COPD Management Market Size by Region (2027-2032) & (US$ Million) Table 20. Global Digital COPD Management Market Share by Region (2027-2032) Table 21. Global Digital COPD Management Revenue by Players (US$ Million) & (2021-2026) Table 22. Global Digital COPD Management Revenue Market Share by Players (2021-2026) Table 23. Global Digital COPD Management Key Players Ranking, 2024 VS 2025 VS 2026 Table 24. Global Digital COPD Management Key Players Headquarters & Area Served Table 25. Global Digital COPD Management Players, Product Type & Application Table 26. Global Digital COPD Management Players Establishment Date Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Digital COPD Management by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Global Digital COPD Management Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Digital COPD Management Revenue by Type (2021-2026) & (US$ Million) Table 31. Global Digital COPD Management Revenue by Type (2027-2032) & (US$ Million) Table 32. Global Digital COPD Management Revenue Market Share by Type (2021-2026) Table 33. Global Digital COPD Management Revenue Market Share by Type (2027-2032) Table 34. Global Digital COPD Management Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Digital COPD Management Revenue by Application (2021-2026) & (US$ Million) Table 36. Global Digital COPD Management Revenue by Application (2027-2032) & (US$ Million) Table 37. Global Digital COPD Management Revenue Market Share by Application (2021-2026) Table 38. Global Digital COPD Management Revenue Market Share by Application (2027-2032) Table 39. Teva Digital Health Company Information Table 40. Teva Digital Health Business Overview Table 41. Teva Digital Health Digital COPD Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Teva Digital Health Digital COPD Management Product Portfolio Table 43. Teva Digital Health Recent Development Table 44. AstraZeneca Digital Health Company Information Table 45. AstraZeneca Digital Health Business Overview Table 46. AstraZeneca Digital Health Digital COPD Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. AstraZeneca Digital Health Digital COPD Management Product Portfolio Table 48. AstraZeneca Digital Health Recent Development Table 49. GSK Digital Health Company Information Table 50. GSK Digital Health Business Overview Table 51. GSK Digital Health Digital COPD Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. GSK Digital Health Digital COPD Management Product Portfolio Table 53. GSK Digital Health Recent Development Table 54. Boehringer Ingelheim Digital Health Company Information Table 55. Boehringer Ingelheim Digital Health Business Overview Table 56. Boehringer Ingelheim Digital Health Digital COPD Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Boehringer Ingelheim Digital Health Digital COPD Management Product Portfolio Table 58. Boehringer Ingelheim Digital Health Recent Development Table 59. Huma Therapeutics Company Information Table 60. Huma Therapeutics Business Overview Table 61. Huma Therapeutics Digital COPD Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Huma Therapeutics Digital COPD Management Product Portfolio Table 63. Huma Therapeutics Recent Development Table 64. Biofourmis Company Information Table 65. Biofourmis Business Overview Table 66. Biofourmis Digital COPD Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Biofourmis Digital COPD Management Product Portfolio Table 68. Biofourmis Recent Development Table 69. Kaia Health Company Information Table 70. Kaia Health Business Overview Table 71. Kaia Health Digital COPD Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Kaia Health Digital COPD Management Product Portfolio Table 73. Kaia Health Recent Development Table 74. Ada Health Company Information Table 75. Ada Health Business Overview Table 76. Ada Health Digital COPD Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Ada Health Digital COPD Management Product Portfolio Table 78. Ada Health Recent Development Table 79. Current Health Company Information Table 80. Current Health Business Overview Table 81. Current Health Digital COPD Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Current Health Digital COPD Management Product Portfolio Table 83. Current Health Recent Development Table 84. Wellinks Company Information Table 85. Wellinks Business Overview Table 86. Wellinks Digital COPD Management Revenue and Gross Margin (US$ Million) & (2021-2026) Table 87. Wellinks Digital COPD Management Product Portfolio Table 88. Wellinks Recent Development Table 89. Sensviv Company Information Table 90. Sensviv Business Overview Table 91. Sensviv Digital COPD Management Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Sensviv Digital COPD Management Product Portfolio Table 93. Sensviv Recent Development Table 94. ResMed Inc Company Information Table 95. ResMed Inc Business Overview Table 96. ResMed Inc Digital COPD Management Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. ResMed Inc Digital COPD Management Product Portfolio Table 98. ResMed Inc Recent Development Table 99. Philips Respironics Company Information Table 100. Philips Respironics Business Overview Table 101. Philips Respironics Digital COPD Management Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. Philips Respironics Digital COPD Management Product Portfolio Table 103. Philips Respironics Recent Development Table 104. Propeller Health Company Information Table 105. Propeller Health Business Overview Table 106. Propeller Health Digital COPD Management Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Propeller Health Digital COPD Management Product Portfolio Table 108. Propeller Health Recent Development Table 109. North America Digital COPD Management Revenue by Type (2021-2026) & (US$ Million) Table 110. North America Digital COPD Management Revenue by Type (2027-2032) & (US$ Million) Table 111. North America Digital COPD Management Revenue by Application (2021-2026) & (US$ Million) Table 112. North America Digital COPD Management Revenue by Application (2027-2032) & (US$ Million) Table 113. North America Digital COPD Management Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Digital COPD Management Revenue by Country (2021-2026) & (US$ Million) Table 115. North America Digital COPD Management Revenue by Country (US$ Million) & (2027-2032) Table 116. Europe Digital COPD Management Revenue by Type (2021-2026) & (US$ Million) Table 117. Europe Digital COPD Management Revenue by Type (2027-2032) & (US$ Million) Table 118. Europe Digital COPD Management Revenue by Application (2021-2026) & (US$ Million) Table 119. Europe Digital COPD Management Revenue by Application (2027-2032) & (US$ Million) Table 120. Europe Digital COPD Management Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 121. Europe Digital COPD Management Revenue by Country (2021-2026) & (US$ Million) Table 122. Europe Digital COPD Management Revenue by Country (US$ Million) & (2027-2032) Table 123. China Digital COPD Management Revenue by Type (2021-2026) & (US$ Million) Table 124. China Digital COPD Management Revenue by Type (2027-2032) & (US$ Million) Table 125. China Digital COPD Management Revenue by Application (2021-2026) & (US$ Million) Table 126. China Digital COPD Management Revenue by Application (2027-2032) & (US$ Million) Table 127. Asia Digital COPD Management Revenue by Type (2021-2026) & (US$ Million) Table 128. Asia Digital COPD Management Revenue by Type (2027-2032) & (US$ Million) Table 129. Asia Digital COPD Management Revenue by Application (2021-2026) & (US$ Million) Table 130. Asia Digital COPD Management Revenue by Application (2027-2032) & (US$ Million) Table 131. Asia Digital COPD Management Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 132. Asia Digital COPD Management Revenue by Region (US$ Million) & (2021-2026) Table 133. Asia Digital COPD Management Revenue by Region (US$ Million) & (2027-2032) Table 134. SAMEA Digital COPD Management Revenue by Type (2021-2026) & (US$ Million) Table 135. SAMEA Digital COPD Management Revenue by Type (2027-2032) & (US$ Million) Table 136. SAMEA Digital COPD Management Revenue by Application (2021-2026) & (US$ Million) Table 137. SAMEA Digital COPD Management Revenue by Application (2027-2032) & (US$ Million) Table 138. SAMEA Digital COPD Management Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 139. SAMEA Digital COPD Management Revenue by Country (2021-2026) & (US$ Million) Table 140. SAMEA Digital COPD Management Revenue by Country (US$ Million) & (2027-2032) Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Digital COPD Management Image Figure 2. Global Digital COPD Management Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Digital COPD Management Market Size Share 2021 VS 2025 VS 2032 Figure 4. Symptom Monitoring Image Figure 5. Lung Function Management Image Figure 6. Acute Exacerbation Prediction Image Figure 7. Medication Adherence Management Image Figure 8. Others Image Figure 9. Global Digital COPD Management Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Digital COPD Management Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Respiratory Department Management Image Figure 12. Home Health Self-Management Image Figure 13. Insurance-Based Health Management Image Figure 14. Telemedicine Image Figure 15. Global Digital COPD Management Market Size (US$ Million) & (2021-2032) Figure 16. Global Digital COPD Management Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Digital COPD Management Market Share by Region: 2021 VS 2025 VS 2032 Figure 18. Global Digital COPD Management Players Revenue Share Top 10 and Top 5 in 2025 Figure 19. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Digital COPD Management Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Digital COPD Management Revenue Market Share 2021 VS 2025 VS 2032 Figure 22. Global Digital COPD Management Revenue Market Share by Type (2021-2032) Figure 23. Global Digital COPD Management Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Digital COPD Management Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 25. Global Digital COPD Management Revenue Market Share by Application (2021-2032) Figure 26. North America Digital COPD Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 27. North America Digital COPD Management Revenue Share by Type (2021-2032) Figure 28. North America Digital COPD Management Revenue Share by Application (2021-2032) Figure 29. North America Digital COPD Management Revenue Share by Country (2021-2032) Figure 30. United States Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Canada Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Mexico Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. Europe Digital COPD Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 34. Europe Digital COPD Management Revenue Share by Type (2021-2032) Figure 35. Europe Digital COPD Management Revenue Share by Application (2021-2032) Figure 36. Europe Digital COPD Management Revenue Share by Country (2021-2032) Figure 37. Germany Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. France Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. U.K. Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Italy Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Spain Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Russia Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Netherlands Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. Nordic Countries Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 45. China Digital COPD Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. China Digital COPD Management Revenue Share by Type (2021-2032) Figure 47. China Digital COPD Management Revenue Share by Application (2021-2032) Figure 48. Asia Digital COPD Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 49. Asia Digital COPD Management Revenue Share by Type (2021-2032) Figure 50. Asia Digital COPD Management Revenue Share by Application (2021-2032) Figure 51. Asia Digital COPD Management Revenue Share by Region (2021-2032) Figure 52. Japan Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. South Korea Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. India Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Australia Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Taiwan Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. Southeast Asia Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. SAMEA Digital COPD Management Revenue YoY Growth (2021-2032) & (US$ Million) Figure 59. SAMEA Digital COPD Management Revenue Share by Type (2021-2032) Figure 60. SAMEA Digital COPD Management Revenue Share by Application (2021-2032) Figure 61. SAMEA Digital COPD Management Revenue Share by Country (2021-2032) Figure 62. Brazil Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Argentina Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Chile Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Colombia Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Peru Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Saudi Arabia Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Israel Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. UAE Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Turkey Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Iran Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Egypt Digital COPD Management Revenue YoY Growth (US$ Million) & (2021-2032) Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Symptom Monitoring
  • Lung Function Management
  • Acute Exacerbation Prediction
  • Medication Adherence Management
  • Others
Applications
  • Hospital Respiratory Department Management
  • Home Health Self-Management
  • Insurance-Based Health Management
  • Telemedicine
Companies covered
  • Teva Digital Health
  • AstraZeneca Digital Health
  • GSK Digital Health
  • Boehringer Ingelheim Digital Health
  • Huma Therapeutics
  • Biofourmis
  • Kaia Health
  • Ada Health
  • Current Health
  • Wellinks
  • Sensviv
  • ResMed Inc
  • Philips Respironics
  • Propeller Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Digital COPD Management Market by Type
  3. 1.2.1 Global Digital COPD Management Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Symptom Monitoring
  5. 1.2.3 Lung Function Management
  6. 1.2.4 Acute Exacerbation Prediction
  7. 1.2.5 Medication Adherence Management
  8. 1.2.6 Others
  9. 1.3 Digital COPD Management Market by Application
  10. 1.3.1 Global Digital COPD Management Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital Respiratory Department Management
  12. 1.3.3 Home Health Self-Management
  13. 1.3.4 Insurance-Based Health Management
  14. 1.3.5 Telemedicine
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Digital COPD Management Market Dynamics
  1. 2.1 Digital COPD Management Industry Trends
  2. 2.2 Digital COPD Management Industry Drivers
  3. 2.3 Digital COPD Management Industry Opportunities and Challenges
  4. 2.4 Digital COPD Management Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Digital COPD Management Market Perspective (2021-2032)
  2. 3.2 Global Digital COPD Management Growth Trends by Region
  3. 3.2.1 Global Digital COPD Management Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Digital COPD Management Market Size by Region (2021-2026)
  5. 3.2.3 Global Digital COPD Management Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Digital COPD Management Revenue by Players
  2. 4.1.1 Global Digital COPD Management Revenue by Players (2021-2026)
  3. 4.1.2 Global Digital COPD Management Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Digital COPD Management Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Digital COPD Management Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Digital COPD Management Key Players Headquarters & Area Served
  7. 4.4 Global Digital COPD Management Players, Product Type & Application
  8. 4.5 Global Digital COPD Management Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Digital COPD Management Market CR5 and HHI
  11. 4.6.3 2025 Digital COPD Management Tier 1, Tier 2, and Tier 3
5 Digital COPD Management Market Size by Type
  1. 5.1 Global Digital COPD Management Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Digital COPD Management Revenue by Type (2021-2032)
  3. 5.3 Global Digital COPD Management Revenue Market Share by Type (2021-2032)
6 Digital COPD Management Market Size by Application
  1. 6.1 Global Digital COPD Management Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Digital COPD Management Revenue by Application (2021-2032)
  3. 6.3 Global Digital COPD Management Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Teva Digital Health
  2. 7.1.1 Teva Digital Health Company Information
  3. 7.1.2 Teva Digital Health Business Overview
  4. 7.1.3 Teva Digital Health Digital COPD Management Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Teva Digital Health Digital COPD Management Product Portfolio
  6. 7.1.5 Teva Digital Health Recent Developments
  7. 7.2 AstraZeneca Digital Health
  8. 7.2.1 AstraZeneca Digital Health Company Information
  9. 7.2.2 AstraZeneca Digital Health Business Overview
  10. 7.2.3 AstraZeneca Digital Health Digital COPD Management Revenue and Gross Margin (2021-2026)
  11. 7.2.4 AstraZeneca Digital Health Digital COPD Management Product Portfolio
  12. 7.2.5 AstraZeneca Digital Health Recent Developments
  13. 7.3 GSK Digital Health
  14. 7.3.1 GSK Digital Health Company Information
  15. 7.3.2 GSK Digital Health Business Overview
  16. 7.3.3 GSK Digital Health Digital COPD Management Revenue and Gross Margin (2021-2026)
  17. 7.3.4 GSK Digital Health Digital COPD Management Product Portfolio
  18. 7.3.5 GSK Digital Health Recent Developments
  19. 7.4 Boehringer Ingelheim Digital Health
  20. 7.4.1 Boehringer Ingelheim Digital Health Company Information
  21. 7.4.2 Boehringer Ingelheim Digital Health Business Overview
  22. 7.4.3 Boehringer Ingelheim Digital Health Digital COPD Management Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Boehringer Ingelheim Digital Health Digital COPD Management Product Portfolio
  24. 7.4.5 Boehringer Ingelheim Digital Health Recent Developments
  25. 7.5 Huma Therapeutics
  26. 7.5.1 Huma Therapeutics Company Information
  27. 7.5.2 Huma Therapeutics Business Overview
  28. 7.5.3 Huma Therapeutics Digital COPD Management Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Huma Therapeutics Digital COPD Management Product Portfolio
  30. 7.5.5 Huma Therapeutics Recent Developments
  31. 7.6 Biofourmis
  32. 7.6.1 Biofourmis Company Information
  33. 7.6.2 Biofourmis Business Overview
  34. 7.6.3 Biofourmis Digital COPD Management Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Biofourmis Digital COPD Management Product Portfolio
  36. 7.6.5 Biofourmis Recent Developments
  37. 7.7 Kaia Health
  38. 7.7.1 Kaia Health Company Information
  39. 7.7.2 Kaia Health Business Overview
  40. 7.7.3 Kaia Health Digital COPD Management Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Kaia Health Digital COPD Management Product Portfolio
  42. 7.7.5 Kaia Health Recent Developments
  43. 7.8 Ada Health
  44. 7.8.1 Ada Health Company Information
  45. 7.8.2 Ada Health Business Overview
  46. 7.8.3 Ada Health Digital COPD Management Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Ada Health Digital COPD Management Product Portfolio
  48. 7.8.5 Ada Health Recent Developments
  49. 7.9 Current Health
  50. 7.9.1 Current Health Company Information
  51. 7.9.2 Current Health Business Overview
  52. 7.9.3 Current Health Digital COPD Management Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Current Health Digital COPD Management Product Portfolio
  54. 7.9.5 Current Health Recent Developments
  55. 7.10 Wellinks
  56. 7.10.1 Wellinks Company Information
  57. 7.10.2 Wellinks Business Overview
  58. 7.10.3 Wellinks Digital COPD Management Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Wellinks Digital COPD Management Product Portfolio
  60. 7.10.5 Wellinks Recent Developments
  61. 7.11 Sensviv
  62. 7.11.1 Sensviv Company Information
  63. 7.11.2 Sensviv Business Overview
  64. 7.11.3 Sensviv Digital COPD Management Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Sensviv Digital COPD Management Product Portfolio
  66. 7.11.5 Sensviv Recent Developments
  67. 7.12 ResMed Inc
  68. 7.12.1 ResMed Inc Company Information
  69. 7.12.2 ResMed Inc Business Overview
  70. 7.12.3 ResMed Inc Digital COPD Management Revenue and Gross Margin (2021-2026)
  71. 7.12.4 ResMed Inc Digital COPD Management Product Portfolio
  72. 7.12.5 ResMed Inc Recent Developments
  73. 7.13 Philips Respironics
  74. 7.13.1 Philips Respironics Company Information
  75. 7.13.2 Philips Respironics Business Overview
  76. 7.13.3 Philips Respironics Digital COPD Management Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Philips Respironics Digital COPD Management Product Portfolio
  78. 7.13.5 Philips Respironics Recent Developments
  79. 7.14 Propeller Health
  80. 7.14.1 Propeller Health Company Information
  81. 7.14.2 Propeller Health Business Overview
  82. 7.14.3 Propeller Health Digital COPD Management Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Propeller Health Digital COPD Management Product Portfolio
  84. 7.14.5 Propeller Health Recent Developments
8 North America
  1. 8.1 North America Digital COPD Management Revenue (2021-2032)
  2. 8.2 North America Digital COPD Management Revenue by Type (2021-2032)
  3. 8.2.1 North America Digital COPD Management Revenue by Type (2021-2026)
  4. 8.2.2 North America Digital COPD Management Revenue by Type (2027-2032)
  5. 8.3 North America Digital COPD Management Revenue Share by Type (2021-2032)
  6. 8.4 North America Digital COPD Management Revenue by Application (2021-2032)
  7. 8.4.1 North America Digital COPD Management Revenue by Application (2021-2026)
  8. 8.4.2 North America Digital COPD Management Revenue by Application (2027-2032)
  9. 8.5 North America Digital COPD Management Revenue Share by Application (2021-2032)
  10. 8.6 North America Digital COPD Management Revenue by Country
  11. 8.6.1 North America Digital COPD Management Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Digital COPD Management Revenue by Country (2021-2026)
  13. 8.6.3 North America Digital COPD Management Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Digital COPD Management Revenue (2021-2032)
  2. 9.2 Europe Digital COPD Management Revenue by Type (2021-2032)
  3. 9.2.1 Europe Digital COPD Management Revenue by Type (2021-2026)
  4. 9.2.2 Europe Digital COPD Management Revenue by Type (2027-2032)
  5. 9.3 Europe Digital COPD Management Revenue Share by Type (2021-2032)
  6. 9.4 Europe Digital COPD Management Revenue by Application (2021-2032)
  7. 9.4.1 Europe Digital COPD Management Revenue by Application (2021-2026)
  8. 9.4.2 Europe Digital COPD Management Revenue by Application (2027-2032)
  9. 9.5 Europe Digital COPD Management Revenue Share by Application (2021-2032)
  10. 9.6 Europe Digital COPD Management Revenue by Country
  11. 9.6.1 Europe Digital COPD Management Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Digital COPD Management Revenue by Country (2021-2026)
  13. 9.6.3 Europe Digital COPD Management Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Digital COPD Management Revenue (2021-2032)
  2. 10.2 China Digital COPD Management Revenue by Type (2021-2032)
  3. 10.2.1 China Digital COPD Management Revenue by Type (2021-2026)
  4. 10.2.2 China Digital COPD Management Revenue by Type (2027-2032)
  5. 10.3 China Digital COPD Management Revenue Share by Type (2021-2032)
  6. 10.4 China Digital COPD Management Revenue by Application (2021-2032)
  7. 10.4.1 China Digital COPD Management Revenue by Application (2021-2026)
  8. 10.4.2 China Digital COPD Management Revenue by Application (2027-2032)
  9. 10.5 China Digital COPD Management Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Digital COPD Management Revenue (2021-2032)
  2. 11.2 Asia Digital COPD Management Revenue by Type (2021-2032)
  3. 11.2.1 Asia Digital COPD Management Revenue by Type (2021-2026)
  4. 11.2.2 Asia Digital COPD Management Revenue by Type (2027-2032)
  5. 11.3 Asia Digital COPD Management Revenue Share by Type (2021-2032)
  6. 11.4 Asia Digital COPD Management Revenue by Application (2021-2032)
  7. 11.4.1 Asia Digital COPD Management Revenue by Application (2021-2026)
  8. 11.4.2 Asia Digital COPD Management Revenue by Application (2027-2032)
  9. 11.5 Asia Digital COPD Management Revenue Share by Application (2021-2032)
  10. 11.6 Asia Digital COPD Management Revenue by Country
  11. 11.6.1 Asia Digital COPD Management Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Digital COPD Management Revenue by Country (2021-2026)
  13. 11.6.3 Asia Digital COPD Management Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Digital COPD Management Revenue (2021-2032)
  2. 12.2 SAMEA Digital COPD Management Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Digital COPD Management Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Digital COPD Management Revenue by Type (2027-2032)
  5. 12.3 SAMEA Digital COPD Management Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Digital COPD Management Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Digital COPD Management Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Digital COPD Management Revenue by Application (2027-2032)
  9. 12.5 SAMEA Digital COPD Management Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Digital COPD Management Revenue by Country
  11. 12.6.1 SAMEA Digital COPD Management Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Digital COPD Management Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Digital COPD Management Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research